Healthcare Finance Staff

Pennsylvania's smaller Blue-licensed insurer is boasting of some notable results in its accountable care arrangements and is looking to bring similar contracts to small primary care practices.

After $300 million, thousands of hours of labor and a few lost government careers, one of the biggest disappointments in progressive health policy has reached the end of the road.

If consumers can not make more informed healthcare decisions, they may just end up being skinned alive.

Welander was first hired by St. Charles in 2009 as director of accounting before being promoted to director of finance in 2014.

The nation's second largest insurer is taking some flak for declining a second opinion on its information technology security.

New developers platform hopes to enhance medical diagnostics and research.

Starting next year, health insurers have to give Americans in Medicare Advantage plans and federal exchange policies up-to-date details about which doctors are in their plans and taking new patients.

An increasingly popular strategy in drug plan affordability is again coming under scrutiny from Medicare regulators concerned that some urban seniors are being left out.

17 companies on the Fortune list were either healthcare providers, healthcare services firms or biotech firms.

Health insurers and patients could get a bit of relief after years of paying more and more for biologic speciality pharmaceuticals, but some think there are still barriers to affordability.